Dearborn Dan
SEC insider (Form 3/4/5 filer). CIK 0001975443. Chief Financial Officer at TuHURA Biosciences, Inc./NV (HURA). 8 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2026. Located in TAMPA, FL.
Companies Dearborn Dan has filed insider reports for
- TuHURA Biosciences, Inc./NV (HURA): Officer, Chief Financial Officer
Dearborn Dan
CIK: 0001975443
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TuHURA Biosciences, Inc./NV
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jan 6, 2026HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
273.7K shares- - Dec 12, 2025HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
1.5M shares- - Nov 12, 2024HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
489.8K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
68.4K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
232.6K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
15.7K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
66.7K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
34K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 6, 2026 | HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 273,696 | - | - | Direct |
| Dec 12, 2025 | HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 1,531,367 | - | - | Direct |
| Nov 12, 2024 | HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 489,848 | - | - | Direct |
| Oct 18, 2024 |  KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 68,438 | - | - | Direct |
| Oct 18, 2024 | KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 232,570 | - | - | Direct |
| Oct 18, 2024 | KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 15,744 | - | - | Direct |
| Oct 18, 2024 | KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 66,658 | - | - | Direct |
| Oct 18, 2024 | KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 33,991 | - | - | Direct |
1-8 of 8 transactions